Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

被引:430
|
作者
Gorges, Tobias M. [1 ]
Tinhofer, Ingeborg [3 ]
Drosch, Michael [1 ]
Roese, Lars [1 ]
Zollner, Thomas M. [1 ]
Krahn, Thomas [1 ]
von Ahsen, Oliver [1 ,2 ]
机构
[1] Bayer Pharma AG, D-13353 Berlin, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Drug Metab & Pharmacokinet, Biberach, Germany
[3] Klin Radioonkol & Strahlentherapie, Charite CCM, D-10117 Berlin, Germany
关键词
Circulating tumour cells; Breast cancer; Xenograft; Metastasis; Epithelial-mesenchymal transition; METASTATIC BREAST-CANCER; TYROSINE KINASE INHIBITOR; ADHESION MOLECULE; STEM-CELLS; GROWTH; EXPRESSION; PROSTATE; SURVIVAL; TWIST;
D O I
10.1186/1471-2407-12-178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating tumour cells (CTCs) have shown prognostic relevance in metastatic breast, prostate, colon and pancreatic cancer. For further development of CTCs as a biomarker, we compared the performance of different protocols for CTC detection in murine breast cancer xenograft models (MDA-MB-231, MDA-MB-468 and KPL-4). Blood samples were taken from tumour bearing animals (20 to 200 mm(2)) and analysed for CTCs using 1. an epithelial marker based enrichment method (AdnaTest), 2. an antibody independent technique, targeting human gene transcripts (qualitative PCR), and 3. an antibody-independent approach, targeting human DNA-sequences (quantitative PCR). Further, gene expression changes associated with epithelial-to-mesenchymal transition (EMT) were determined with an EMT-specific PCR assay. Methods: We used the commercially available Adna Test, RT-PCR on human housekeeping genes and a PCR on AluJ sequences to detect CTCs in xenografts models. Phenotypic changes in CTCs were tested with the commercially available "Human Epithelial to Mesenchymal Transition RT-Profiler PCR Array". Results: Although the AdnaTest detects as few as 1 tumour cell in 1 ml of mouse blood spiking experiments, no CTCs were detectable with this approach in vivo despite visible metastasis formation. The presence of CTCs could, however, be demonstrated by PCR targeting human transcripts or DNA-sequences - without epithelial pre-enrichment. The failure of CTC detection by the AdnaTest resulted from downregulation of EpCAM, whereas mesenchymal markers like Twist and EGFR were upregulated on CTCs. Such a change in the expression profile during metastatic spread of tumour cells has already been reported and was linked to a biological program termed epithelial-mesenchymal transition (EMT). Conclusions: The use of EpCAM-based enrichment techniques leads to the failure to detect CTC populations that have undergone EMT. Our findings may explain clinical results where low CTC numbers have been reported even in patients with late metastatic cancers. These results are a starting point for the identification of new markers for detection or capture of CTCs, including the mesenchymal-like subpopulations.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition
    Hsu, Ya-Ting
    Osmulski, Pawel
    Wang, Yao
    Huang, Yi-Wen
    Liu, Lu
    Ruan, Jianhua
    Jin, Victor X.
    Kirma, Nameer B.
    Gaczynska, Maria E.
    Huang, Tim Hui-Ming
    CANCER RESEARCH, 2016, 76 (21) : 6171 - 6182
  • [32] Epithelial-to-mesenchymal markers of circulating tumor cells for detection of castration-resistant prostate cancer
    Chen, Chun-Liang
    Osmulski, Pawel
    Mahalingam, Devalingam
    Horning, Aaron M.
    Jadhav, Rohit R.
    Louie, Anna D.
    Wang, Chiou-Miin
    Huang, Tim H. -M.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Incorporating Epithelial Mesenchymal Plasticity (EMP) in the Detection and Isolation of Circulating and Disseminated Tumour Cells
    Jacobsen, N.
    Dobrovic, A.
    Tachtsidis, A.
    Blick, T.
    Thomas, E.
    Dowling, A.
    Huang, D.
    Zeps, N.
    Saunders, C.
    Thompson, E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S113 - S114
  • [34] Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
    Markiewicz, Aleksandra
    Topa, Justyna
    Nagel, Anna
    Skokowski, Jaroslaw
    Seroczynska, Barbara
    Stokowy, Tomasz
    Welnicka-Jaskiewicz, Marzena
    Zaczek, Anna J.
    CANCERS, 2019, 11 (01)
  • [35] Delamination of cells from neurogenic placodes does not involve an epithelial-to-mesenchymal transition
    Graham, Anthony
    Blentic, Aida
    Duque, Sandra
    Begbie, Jo
    DEVELOPMENT, 2007, 134 (23): : 4141 - 4145
  • [36] Relationship between Stemness, Reactive Oxygen Species, and Epithelial-to-Mesenchymal Transition in Model Circulating Tumor Cells
    Brown, Spenser R.
    Bates, Juliana C.
    Avera, Alexandra D.
    Kim, Yonghyun
    CELLS TISSUES ORGANS, 2022, 211 (03) : 282 - 293
  • [37] Analysis of the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with breast cancer
    Papadaki, Maria A.
    Kallergi, Galaktia
    Agelaki, Sofia
    Polioudaki, Hara
    Mavroudis, Dimitrios
    Georgoulias, Vassilis
    Theodoropoulos, Panayiotis A.
    CANCER RESEARCH, 2012, 72
  • [38] Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer
    Mego, Michal
    Karaba, Marian
    Minarik, Gabriel
    Benca, Juraj
    Silvia, Jurisova
    Sedlackova, Tatiana
    Manasova, Denisa
    Kalavska, Katarina
    Pindak, Daniel
    Cristofanilli, Massimo
    Reuben, James M.
    Mardiak, Jozef
    ANTICANCER RESEARCH, 2019, 39 (04) : 1829 - 1837
  • [39] Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer
    Hou, J.
    Guo, C.
    Lyu, G.
    COLORECTAL DISEASE, 2020, 22 (05) : 581 - 587
  • [40] En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition
    Aceto, Nicola
    Toner, Mehmet
    Maheswaran, Shyamala
    Haber, Daniel A.
    TRENDS IN CANCER, 2015, 1 (01): : 44 - 52